Les personnes handicapées vieillissantes : enjeux socio-économiques, organisationnels, et diagnostics : le cas du syndrome de Down

Les personnes handicapées vieillissantes : enjeux socio-économiques, organisationnels, et diagnostics : le cas du syndrome de Down

Les personnes souffrant d’un syndrome de Down (SD), appelé aussi trisomie 21, ont vu leur espérance de vie augmenter bien au delà des 50 ans induisant l’apparition de démence de type Alzheimer (DTA). Les conséquences de cette augmentation de l'espérance sont multiples : difficulté à diagnostiqu...

Full description

Bibliographic Details
Main Author:	Djoulah, Farida
Other Authors:	Bordeaux
Language:	fr
Published:	2015
Subjects:	Handicap mental Syndrome de Down Vieillissement Outil diagnostic Modélisation organisationnelle Accompagnement Démence de type Alzheimer Mental disability Down syndrome Aging Diagnostic tool Organizational modelling Coaching Alzheimer's type dementia
Online Access:	http://www.theses.fr/2015BORD0003

Similar Items

Microstate Changes Associated With Alzheimer’s Disease in Persons With Down Syndrome
by: Christian Sandøe Musaeus, et al.
Published: (2019-11-01)

Quantitative Electroencephalography as a Diagnostic Tool for Alzheimer's Dementia in Adults with Down Syndrome
by: Lise Cronberg Salem, et al.
Published: (2015-10-01)

DOWN SYNDROME: ADVANCES AND PERSPECTIVES
by: Sócrates Bezerra de Matos, et al.
Published: (2007-04-01)

Down Syndrome: advances and perspectives
by: Ciro Silveira e Pereira,, et al.
Published: (2007-01-01)

Alzheimer Disease in Down Syndrome
by: J Gordon Millichap
Published: (1989-08-01)

The AT(N) framework for Alzheimer's disease in adults with Down syndrome
by: Michael S. Rafii, et al.
Published: (2020-01-01)

Is Memantine a Potential Therapeutic for Rett Syndrome?
by: Olivia eBello, et al.
Published: (2013-12-01)

The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome
by: Yvonne S. Davidson, et al.
Published: (2018-07-01)

Comparison of the neuropsychological function in adults with Down syndrome with and without Alzheimer disease
by: shahla pezeshk, et al.
Published: (2016-07-01)

Acute Regression in Down Syndrome
by: Benjamin Handen, et al.
Published: (2021-08-01)

Capgras syndrome and intellectual disability in Down Syndrome: A case report (eng)
by: Burcu Akın Sarı
Published: (2021-09-01)

Williams and Down Syndromes
by: J Gordon Millichap
Published: (1989-08-01)

Traitement de l'angoisse du sujet dément : Exorde pour une métapsychologie de la démence au stade sévère
by: Guentcheff, Ianis
Published: (2014)

Adiponectin Modulation by Genotype and Maternal Choline Supplementation in a Mouse Model of Down Syndrome and Alzheimer’s Disease
by: Melissa J. Alldred, et al.
Published: (2021-07-01)

Perception de personnes atteintes de la maladie d'Alzheimer du soutien provenant de leur réseau social formel et informel dans les périodes précédant et suivant le diagnostic
by: Thorn, Karine
Published: (2017)

The life-world of Indian parents' with a down's syndrome child
by: Moola, H.H.
Published: (2011)

A case study of a Mongolian child

Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity
by: Miren Altuna, et al.
Published: (2021-06-01)

Signalling Pathways Implicated in Alzheimer′s Disease Neurodegeneration in Individuals with and without Down Syndrome
by: Carmen Martínez-Cué, et al.
Published: (2020-09-01)

Behavioral and psychological symptoms of Alzheimer’s disease in adults with Down syndrome: a comparative study
by: Masumeh Tayebli, et al.
Published: (2017-07-01)

Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain
by: Aurélie Ledreux, et al.
Published: (2021-08-01)

Notch signaling in the pathologic adult brain
by: Mathieu Patricia, et al.
Published: (2013-10-01)

Alzheimer‐related altered white matter microstructural integrity in Down syndrome: A model for sporadic AD?
by: H. Diana Rosas, et al.
Published: (2020-01-01)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
by: Sigan L. Hartley, et al.
Published: (2020-01-01)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
by: Benjamin L. Handen, et al.
Published: (2020-01-01)

mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy
by: Marzia Perluigi, et al.
Published: (2015-12-01)

Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
by: Antonella Tramutola, et al.
Published: (2020-04-01)

Adulte vieillissant et personne Alzheimer en EHPAD : Dépendance et handicap
by: Gastaud, Pierre-Guy
Published: (2015)

Usages et pratiques socio-(re)éducommunicationnels pour les personnes handicapées mentales : outils informatiques et média Internet
by: Bonjour, Audrey
Published: (2011)

VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome
by: Alberto Lleó, et al.
Published: (2021-06-01)

The promotion of physical activity for the prevention of Alzheimer's disease in adults with Down Syndrome: Rationale and design for a 12 Month randomized trial
by: Lauren T. Ptomey, et al.
Published: (2020-09-01)

Comparison of senile executive function with Down syndrome with and without Alzheimer's disorder
by: Fereshteh Yaghooti, et al.
Published: (2018-11-01)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
by: Carla M. Startin, et al.
Published: (2019-03-01)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
by: Alain D. Dekker, et al.
Published: (2017-01-01)

Cellular Senescence in Neurodegenerative Diseases
by: Carmen Martínez-Cué, et al.
Published: (2020-02-01)

The validity and reliability of the CAMDEX-DS for assessing dementia in adults with Down syndrome in Brazil
by: Luciana M. Fonseca, et al.
Published: (2018-10-01)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
by: Andre Strydom, et al.
Published: (2018-04-01)

Down Syndrome, Obesity, Alzheimer’s Disease, and Cancer: A Brief Review and Hypothesis
by: Daniel W. Nixon
Published: (2018-03-01)

Role of metal ions in the cognitive decline of Down syndrome
by: Nakisa eMalakooti, et al.
Published: (2014-06-01)

Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
by: Melissa Petersen, et al.
Published: (2020-01-01)